^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Penile Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) + paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Treatment...chemotherapy for advanced disease...Paclitaxel in combination with carboplatin may provide an alternative regimen in patients who are ineligible for cisplatin treatment.
